Goal Directed Hemodynamic Management and Renal Outcome After Major Non-cardiac Surgery (IROM)

January 16, 2013 updated by: Technical University of Munich

Can Goal Directed Hemodynamic Management Improve Renal Outcome After Major Non-cardiac Surgery?

This study is designed to compare renal outcome of patients following major non-cardiac surgery with different perioperative hemodynamic managements: a goal directed hemodynamic management group (using PiCCO) and a control group.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Acute kidney injury (AKI) is a common complication after major surgery. Many studies showed that AKI is associated with different complications: higher mortality, renal replacement therapy and prolonged hospital stay resulting in higher health care costs.

Until now just a few studies are published on prevention or therapy of AKI after major surgery. Most of these investigations are underpowered or show just marginal benefit. There are no studies published investigating the impact of goal-directed hemodynamic management on renal outcome following non-cardiac major surgery, even though hemodynamic stability seems to be of paramount importance for the kidneys.

Aim of this study is to investigate the impact of a goal directed hemodynamic management on renal outcome after major non-cardiac surgery.

Therefore patients will be randomized in one of two groups, the PiCCO group with goal directed hemodynamic management and the Control group, where PICCO data will be collected but will not influence hemodynamic management. In both groups the monitoring with transpulmonary thermodilution will be continued in the intensive care unit until 72 hours after surgery.

Study Type

Observational

Enrollment (Actual)

180

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bavaria
      • Munic, Bavaria, Germany, 81675
        • Klinik für Anaesthesiologie, Klinikum rechts der Isar der Technischen Universität München

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients udndergoing Major non-cardiac surgery

Description

Inclusion Criteria:

  • Elective major non-cardiac surgery lasting more than 3 hours with a following intensive care unit stay for more than 3 days:

    • gastrectomy
    • pancreas surgery
    • small bowel surgery
    • esophageal surgery
  • Age ≥ 18 years
  • ASA classification I to III
  • Written informed consent

Exclusion Criteria:

  • Need for dialysis
  • Contraindications for an arterial line in the femoral artery:

    • stents
    • bypasses
    • severe peripheral artery occlusive disease
  • ASA classification IV to V
  • Pregnant Woman

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
P group
Fluid Management according to measurements with PiCCO®
Fluid and vasopressor management according to PiCCO measruements
C group
Conventional fluid management
Fluid and vasopressor management according to PiCCO measruements

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
maximum change in serum creatinine within 3 days
Time Frame: Start of anesthesia until third postoperative day (72 hours)
Start of anesthesia until third postoperative day (72 hours)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
incidence of AKI according to the RIFLE criteria, need for dialysis, pulmonal complications, rate of anastomotic insufficiency, sepsis, reoperation
Time Frame: 1 year
All points are additionnally registered one year after the operation via telephone-questionnaire of the patient and his general practitioner
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2009

Primary Completion (Actual)

December 1, 2012

Study Registration Dates

First Submitted

December 17, 2009

First Submitted That Met QC Criteria

December 17, 2009

First Posted (Estimate)

December 18, 2009

Study Record Updates

Last Update Posted (Estimate)

January 17, 2013

Last Update Submitted That Met QC Criteria

January 16, 2013

Last Verified

January 1, 2013

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Major Non-cardiac Surgery

Clinical Trials on PiCCO® Monitoring

Subscribe